CN Stock MarketDetailed Quotes

Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130)

Watchlist
  • 32.12
  • +0.50+1.58%
Market Closed Apr 30 15:00 CST
2.46BMarket Cap107.79P/E (TTM)

Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
利培酮口崩片103.7M44.16%
复方硫酸亚铁叶酸片94.64M40.30%
草酸艾司西酞普兰片14.93M6.36%
瑞香素胶囊8.14M3.47%
富马酸亚铁原料药6.69M2.85%
硫酸亚铁原料药2.45M1.04%
奥氮平口崩片1.92M0.82%
阿魏酸钠原料药1.88M0.80%
Other business443.91K0.19%
Other35.22K0.01%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical main business234.4M99.81%
Other business443.91K0.19%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
South China46.33M19.73%
Central China36.58M15.58%
East China region34.13M14.53%
Northeast area31.59M13.45%
Southwest area29.33M12.49%
North China28.22M12.02%
Northwest region28.22M12.02%
Other business443.91K0.19%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More